Cardiovascular Journal of Africa: Vol 26 No 2 Supplement (March/April 2015)

27 / 64

AFRICA S25
CVJAFRICA • Volume 26, No 2, H3Africa Supplement, March/April 2015
the African region: current situation and perspectives – report of
the regional director 2005.
8. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden
of group A streptococcal diseases. Lancet Infect Dis 2005; 5: 685–694
9. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, et
al. Prevalence of rheumatic heart disease detected by echocardiographic
screening. N Engl J Med 2007; 357: 470–476.
10. Rossi E, Felici AR, Banteyrga L. Subclinical rheumatic heart disease
in an Eritrean high-school population, detected by echocardiography. J
Heart Valve Dis 2014; 23(2): 235–239.
11. Beaton A, Okello E, Aliku T, Lubega S, Lwabi P, Mondo C, et al. Latent
rheumatic heart disease: outcomes 2 years after echocardiographic
detection. Pediatr Cardiol 2014; 35(7): 1259–1267. doi: 10.1007/s00246-
014-0925-3.
12. Carapetis J. Rheumatic heart disease in developing countries. N Engl J
Med 2007; 357(5): 439–441.
13. Parks T, Smeesters PR, Steer AC. Streptococcal skin infection and
rheumatic heart disease. Curr Opin Infect Dis 2012; 25(2): 145–153. doi:
.0b013e3283511d27.
14. Viswanathan V. Acute rheumatic fever. Indian J Rheumatol 2012; 7(1):
36–43.
15. Delunardo F, Scalzi V, Capozzi A, Camerini S, Misasi R, Pierdominici
M, et al. Streptococcal-vimentin cross-reactive antibodies induce micro-
vascular cardiac endothelial proinflammatory phenotype in rheumatic
heart disease. Clin Exp Immunol 2013; 173(3): 419–429. doi:
12135.
16. Guilherme L, Kalil J. Rheumatic fever and rheumatic heart disease:
cellular mechanisms leading autoimmune reactivity and disease. J Clin
Immunol 2010; 30: 17–23.
17. Guilherme L, Kalil J. Rheumatic heart disease: molecules involved
in valve tissue inflammation leading to the autoimmune process and
anti-S. pyogenes vaccine. Front Immunol 2013; 4: 352. doi:
2013.00352.
18. Guilherme L, Kalil J. Rheumatic fever – from innate to acquire immune
response. Ann NY Acad Sci 2007; 1107 : 426-433
19. Cunningham MW. Molecular mimicry, autoimmunity and infection in
the pathogenesis of rheumatic fever. Int Congr Ser 2006; 1289 : 14–19.
20. Love GL, Restrepo C. Aschoff bodies of rheumatic carditis are granu-
lomatous lesions of histiocytic origin. Mod Pathol 1988; 1(4): 256–261.
21. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran
Pathologic Basis of Disease. 8th edn. Philadelphia: Elsevier Inc, 2010.
22. McPhee SJ, Papadakis MA. 2011 Current Medical Diagnosis &
Treatment. 50th edn. United States: McGraw-Hill, 2011.
23. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart
disease. Lancet 2012; 379: 953–964.
24. Júnior AR, Oliveira CD, Fontes MJ, Lasmar LM, Camargos EP.
Diagnosis of streptococcal pharyngotonsillitis in children and adoles-
cents: clinical picture limitations. Rev Paul Pediatr 2014; 32(4): 285–291.
doi: .2014.04.001. Portuguese.
25. Leung AK, Newman R, Kumar A, Davies HD. Rapid antigen detection
testing in diagnosing group A β-hemolytic streptococcal pharyngitis.
Expert Rev Mol Diagn 2006; 6(5): 761–766.
26. Parks T, Kado J, Colquhoun S, Carapetis J, Steer A. Underdiagnosis
of acute rheumatic fever in primary care settings in a developing
country. Trop Med Int Health 2009; 14: 1407–1413. doi: 10.1111/j.1365-
3156.2009.02385.x
27. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart
S. Incidence and characteristics of newly diagnosed rheumatic heart
disease in urban African adults: insights from the heart of Soweto study.
Eur Heart J 2010; 31(6): 719–727. doi: 530. Epub
2009 Dec 7.
28. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart
disease. Lancet 2012; 379: 953–964.
29. Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, et al .
World Heart Federation criteria for echocardiographic diagnosis of
rheumatic heart disease – an evidence-based guideline. Nat Rev Cardiol
2012; 9(5): 297–309.
30. Zühlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido
B, et al. Characteristics, complications, and gaps in evidence-based
interventions in rheumatic heart disease: the Global Rheumatic Heart
Disease Registry (the REMEDY study). Eur Heart J 2014. pii: ehu449.
31. Essop MR, Nkomo VT. Rheumatic and Non-rheumatic valvular
heart disease: epidemiology, management and prevention in Africa.
Circulation 2005; 112: 3584–3591.
32. Tadele H, Mekonnen W, Tefera E. Rheumatic mitral stenosis in chil-
dren: more accelerated course in sub-Saharan patients. BMC Cardiovasc
Dis 2013; 13: 95. doi:10.1186/1471-2261-13-95.
33. Currie BJ.
Pediatrics
1996; 97(6 Pt 2): 989–991.
34. Guéant JL, Romano A, Cornejo-Garcia JA, Oussalah A, Chery C,
Blanca-López N, et al. HLA-DRA variants predict penicillin allergy in
genome-wide fine-mapping genotyping. J Allergy Clin Immunol 2014.
pii: S0091-6749(14)01051-3. doi: 2014.07.047
35. Cunningham MW. Streptococcus and rheumatic fever. Curr Opin
Rheumatol 2012; 24: 408–416.
36. Gourley M, Miller FW. Mechanisms of disease: environmental factors
in the pathogenesis of rheumatic disease . Nat Clin Pract Rheum 2007;
3: 172–180.
37. Azevedo PM, Pereira RR, Guilherme L. Understanding rheumatic
fever. Rheumatol Int 2012; 32(5): 1113–1120. doi: 10.1007/s00296-011-
2152-z.
38. Engel ME, Stander R, Vogel J, Adeyemo AA, Mayosi BM. Genetic
susceptibility to acute rheumatic fever: a systematic review and meta-
analysis of twin studies. PLoS One 2011; 6(9): e25326. doi:
.0025326. Epub 2011 Sep 30.
39. Guilherme L, Köhler K F, Postol E, Kalil J. Genes, autoimmunity and
pathogenesis of rheumatic heart disease. Ann Pediatr Card 2011; 4:
13–21.
40. Bryant PA, Robins-Browne R, Carapetis JR, Curtis N. Some of the
people, some of the time: Susceptibility to acute rheumatic fever.
Circulation 2009; 119: 742–753.
41. Gupta U, Mir SS, Chauhan T, Garg N, Agarwal SK, Pande S, et al .
Influence of protein tyrosine phosphatase gene (PTPN22) polymor-
phisms on rheumatic heart disease susceptibility in North Indian popu-
lation. Tissue Antigens 2014; 84(5): 492–496.
42. Gupta U, Mir SS, Srivastava A, Garg N, Agarwal SK, Pande S, Mittal
B. Signal transducers and activators of transcription (STATs) gene
polymorphisms related with susceptibility to rheumatic heart disease in
north Indian population. Immunol Lett 2014; 161(1): 100–105.
43. Gupta U, Mishra A, Rathore SS, Agarwal SK, Pande S, Garg N, Mittal
B. Association of angiotensin I-converting enzyme gene insertion/dele-
tion polymorphism with rheumatic heart disease in Indian population
and meta-analysis. Mol Cell Biochem 2013; 382(1–2): 75–82.
44. Mohamed AA, Rashed LA, Shaker SM, Ammar RI. Association of
tumor necrosis factor-alpha polymorphisms with susceptibility and
clinical outcomes of rheumatic heart disease. Saudi Med J 2010; 31(6):
644–649.
45. Rehman S, Akhtar N, Ahmad W, Ayub Q, Mehdi SQ, Mohyuddin A.